BUZZ-Lycia Therapeutics shares surge on Nasdaq debut after its IPO size was increased to 317.5 millions dollars
路透社2026/10/23 16:51Latest Updates
October 23 - ** Lycia Therapeutics LYCA.O soared 27.5% in its Nasdaq debut, after its US initial public offering (IPO) was upsized to $317.5 million
** The drug development company's shares opened at $28.55 each, while the IPO was priced at $18 (link)
** South San Francisco, California-based LYCA sold 17.6 million shares at the top end of its $16-18 price range (link) (link)
** The fall 2026 IPO window is focused mainly on biotech, as higher borrowing costs and market volatility restrain other sectors (link)
** The window has been turbulent due to a string of high-profile postponements as investors become more selective
** LYCA, founded by Nobel laureate Carolyn Bertozzi, is developing drugs to treat autoimmune, inflammatory and allergic diseases
** Jefferies, TD Cowen, Evercore ISI and Guggenheim Securities are joint bookrunners on the LYCA offering
(To facilitate non-native English speakers, Reuters has automated the translation of its reports into various other languages. Due to possible inaccuracies or lack of required context in automated translations, Reuters does not guarantee the accuracy of the translated text, which is provided solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by use of the automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The AI arms race extends upstream! Reports say Intel, Nvidia, and AMD are prepaying over 100 billions NTD to secure advanced IC substrate production capacity.
NVIDIA, Intel, and AMD have collectively spent $5 billion in advance payments to aggressively secure high-end IC substrates from Taiwan. Driven by "big money for guaranteed orders," the top three Taiwanese substrate manufacturers have invested a record NT$161.2 billion to expand their production capacity. The tech giants' substantial financial commitments to secure supply chains highlight the intense competition and extreme scarcity of core AI materials.
Brent Crude Oil Hits $116 as Markets Weigh Another Inflation Shock
S&P rewrites stock classification rules! $375 billions in funds may be forced to rebalance, major reshuffle for growth and value stocks
After S&P Dow Jones Indices adopts new stock classification rules, growth stocks and value stocks will undergo a reshuffling.
Crypto prices
More
